SUVEN2019-07-012019-09-30in-bse-fin:OneOperatingExpenses01Member SUVEN2019-07-012019-09-30in-bse-fin:OneOperatingExpenses02Member SUVEN2019-07-012019-09-30in-bse-fin:OneOperatingExpenses03Member SUVEN2019-07-012019-09-30in-bse-fin:FourOperatingExpenses01Member SUVEN2019-07-012019-09-30in-bse-fin:FourOperatingExpenses02Member SUVEN2019-07-012019-09-30in-bse-fin:FourOperatingExpenses03Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentRevenue01Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentRevenue02Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentRevenue03Member SUVEN2019-07-012019-09-30in-bse-fin:FourReportableSegmentRevenue01Member SUVEN2019-07-012019-09-30in-bse-fin:FourReportableSegmentRevenue02Member SUVEN2019-07-012019-09-30in-bse-fin:FourReportableSegmentRevenue03Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentResults01Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentResults02Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentResults03Member SUVEN2019-07-012019-09-30in-bse-fin:FourReportableSegmentResults01Member SUVEN2019-07-012019-09-30in-bse-fin:FourReportableSegmentResults02Member SUVEN2019-07-012019-09-30in-bse-fin:FourReportableSegmentResults03Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentAssets01Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentAssets02Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentAssets03Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentLiabilities01Member SUVEN2019-09-30in-bse-fin:OneReportableSegmentLiabilities01Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentLiabilities02Member SUVEN2019-09-30in-bse-fin:OneReportableSegmentLiabilities02Member SUVEN2019-07-012019-09-30in-bse-fin:OneReportableSegmentLiabilities03Member SUVEN2019-09-30in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares SUVEN 2019-04-01 2020-03-31 2019-11-06 INR Lakhs Half yearly Multi segment 2019-07-01 2019-09-30 Unaudited Standalone 2743149000.00 55852000.00 2799001000.00 604763000.00 0.00 305782000.00 168458000.00 18541000.00 55908000.00 558801000.00 1712253000.00 1086748000.00 0.00 1086748000.00 364651000.00 -1094000.00 363557000.00 0.00 723191000.00 0.00 0.00 0.00 0.00 723191000.00 -344000.00 722847000.00 0.00 0.00 127282000.00 1 5.68 5.68 0.00 0.00 5.68 5.68 1) The above results were reviewed by Audit Committee of the Board and approved by the Board of Directors' at their Meeting held on 14th Nov 2019 and the same has been reviewed by the Statutory Auditors. n2) The Company is in the process of evaluating the impact of newly introduced Sec.115BAA of the Taxation Laws (Amendments) Ordinance, 2019. n3) The acquisition of Assets and Liabilities in RISING PHARMA HOLDINGS, Inc., under the US Bankruptcy Code are still under process. Hence, the company did not consider RISING PHARMA HOLDINGS, Inc. for consolidation. n4) The corresponding previous period figures have been regrouped / reclassified where ever necessary. 2019-04-01 2019-09-30 Unaudited Standalone 4733012000.00 85919000.00 4818931000.00 1191394000.00 0.00 132568000.00 355999000.00 31616000.00 111411000.00 1047379000.00 2870367000.00 1948564000.00 0.00 1948564000.00 713012000.00 -59416000.00 653596000.00 0.00 1294968000.00 0.00 0.00 0.00 0.00 1294968000.00 -688000.00 1294280000.00 0.00 0.00 127282000.00 10 10.17 10.17 0.00 0.00 10.17 10.17 Manufacturing Exps 276242000.00 Other Expenses 135916000.00 R & D Exps 146643000.00 Manufacturing Exps 529710000.00 Other Expenses 240012000.00 R & D Exps 277657000.00 Manufacturing (CRAMS) 2670993000.00 Research & Development 0.00 Services (DDDSS) 72156000.00 Manufacturing (CRAMS) 4632628000.00 Research & Development 0.00 Services (DDDSS) 100384000.00 2743149000.00 4733012000.00 0.00 0.00 2743149000.00 4733012000.00 Manufacturing (CRAMS) 1254133000.00 Research & Development -146642000.00 Services (DDDSS) 10053000.00 Manufacturing (CRAMS) 2312891000.00 Research & Development -277657000.00 Services (DDDSS) 16073000.00 1117544000.00 2051307000.00 6985000.00 11626000.00 23811000.00 91117000.00 1086748000.00 1948564000.00 Manufacturing (CRAMS) 7433200000.00 Research & Development 288912000.00 Services (DDDSS) 567523000.00 8289635000.00 5669857000.00 13959492000.00 Manufacturing (CRAMS) 1784998000.00 Research & Development 213652000.00 Services (DDDSS) 64876000.00 2063526000.00 136226000.00 2199752000.00